Annual Cash & Cash Equivalents
$176.05 M
+$108.56 M+160.86%
December 31, 2023
Summary
- As of February 7, 2025, SWTX annual cash & cash equivalents is $176.05 million, with the most recent change of +$108.56 million (+160.86%) on December 31, 2023.
- During the last 3 years, SWTX annual cash & cash equivalents has risen by +$28.96 million (+19.69%).
- SWTX annual cash & cash equivalents is now -46.27% below its all-time high of $327.65 million, reached on December 31, 2019.
Performance
SWTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$84.46 M
+$4.56 M+5.70%
September 30, 2024
Summary
- As of February 7, 2025, SWTX quarterly cash and cash equivalents is $84.46 million, with the most recent change of +$4.56 million (+5.70%) on September 30, 2024.
- Over the past year, SWTX quarterly cash and cash equivalents has increased by +$4.56 million (+5.70%).
- SWTX quarterly cash and cash equivalents is now -82.27% below its all-time high of $476.43 million, reached on September 30, 2022.
Performance
SWTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SWTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +160.9% | +5.7% |
| 3 y3 years | +19.7% | +5.7% |
| 5 y5 years | +285.7% | +5.7% |
SWTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +160.9% | -82.3% | +25.1% |
| 5 y | 5-year | -46.3% | +160.9% | -82.3% | +25.1% |
| alltime | all time | -46.3% | +1614.1% | -82.3% | +85.0% |
SpringWorks Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $84.46 M(+5.7%) |
| Jun 2024 | - | $79.90 M(-32.3%) |
| Mar 2024 | - | $118.03 M(-33.0%) |
| Dec 2023 | $176.05 M(+160.9%) | $176.05 M(+78.0%) |
| Sep 2023 | - | $98.89 M(-14.0%) |
| Jun 2023 | - | $115.00 M(+12.3%) |
| Mar 2023 | - | $102.40 M(+51.7%) |
| Dec 2022 | $67.49 M(-35.1%) | $67.49 M(-85.8%) |
| Sep 2022 | - | $476.43 M(+584.8%) |
| Jun 2022 | - | $69.57 M(-15.1%) |
| Mar 2022 | - | $81.93 M(-21.2%) |
| Dec 2021 | $103.96 M | $103.96 M(+10.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $93.85 M(+11.0%) |
| Jun 2021 | - | $84.57 M(-11.4%) |
| Mar 2021 | - | $95.43 M(-35.1%) |
| Dec 2020 | $147.09 M(-55.1%) | $147.09 M(+73.4%) |
| Sep 2020 | - | $84.83 M(-62.6%) |
| Jun 2020 | - | $226.67 M(-27.1%) |
| Mar 2020 | - | $311.07 M(-5.1%) |
| Dec 2019 | $327.65 M(+617.8%) | $327.65 M(-4.7%) |
| Sep 2019 | - | $343.82 M(+85.6%) |
| Jun 2019 | - | $185.29 M(+305.9%) |
| Dec 2018 | $45.65 M(+344.4%) | $45.65 M |
| Dec 2017 | $10.27 M | - |
FAQ
- What is SpringWorks Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics annual cash & cash equivalents year-on-year change?
- What is SpringWorks Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for SpringWorks Therapeutics?
- What is SpringWorks Therapeutics quarterly cash and cash equivalents year-on-year change?
What is SpringWorks Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SWTX is $176.05 M
What is the all time high annual cash & cash equivalents for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high annual cash & cash equivalents is $327.65 M
What is SpringWorks Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SWTX annual cash & cash equivalents has changed by +$108.56 M (+160.86%)
What is SpringWorks Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SWTX is $84.46 M
What is the all time high quarterly cash and cash equivalents for SpringWorks Therapeutics?
SpringWorks Therapeutics all-time high quarterly cash and cash equivalents is $476.43 M
What is SpringWorks Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, SWTX quarterly cash and cash equivalents has changed by +$4.56 M (+5.70%)